ALPHA TRIBE

Transgene Biotek LtdImportant, 02-06-2026: Company Update

02-06-2026 | 03:44 pm

Here are the summaries for the announcements in the document:

**Transgene Biotek Limited**

Transgene Biotek has released its audited financial results for the quarter and year ended March 31, 2026. For both the quarter and the full year, the company reported a total income from operations of 0.20 Cr and a net loss of 0.46 Cr, resulting in basic earnings per share of -0.06. These figures reflect consistent financial performance for the period.

**Sundrop Brands Limited**

Sundrop Brands Limited has notified shareholders about a special window for transferring and dematerializing physical securities. This window is open for one year until February 4, 2027, for shares sold/purchased before April 1, 2019, or those with previously rejected transfer requests. Transferred securities will be mandatorily credited in demat mode and locked in for one year. Shareholders are advised to contact the company's RTA.

**Balaji Agro Oils Limited**

Balaji Agro Oils has announced its audited financial results for the year ended March 31, 2026. The company reported total revenue of 151.55 Cr and a net profit of 1.32 Cr, with basic earnings per share of 1.25. The Solvent Extraction division contributed significantly with 103.83 Cr in revenue, while the Rice division generated 54.02 Cr in revenue, highlighting key business segments.

**Regency Ceramics Limited**

Regency Ceramics has released its audited financial results for the quarter and year ended March 31, 2026. For the quarter, total income from operations was 11.26 Cr, but the company recorded a net loss of 12.49 Cr, leading to basic earnings per share of -4.73. The full year saw total income reach 38.27 Cr, with a net loss of 23.84 Cr and basic EPS of -9.02.

**Madala Holdings Limited**

Madala Holdings (formerly Softsol India) has announced its audited financial results for the quarter and year ended March 31, 2026. For the quarter, total income was 3.59 Cr, with a net loss of 7.21 Cr and basic EPS of -4.88. However, the full year showed a profit of 2.71 Cr on 13.77 Cr total income, with basic EPS of 1.83. These results reflect the demerger of its IT/ITES business.

No comments yet. Be the first to comment!

All announcements from Transgene Biotek Ltd